Document is current
Any future updates will be listed below
-
Authors
Curti, Brendan https://orcid.org/0000-0003-3948-2708
Crittenden, Marka
Seung, Steven K
Fountain, Christopher B
Payne, Roxanne
Chang, ShuChing
Fleser, Jessica
Phillips, Kimberly
Malkasian, Ian
Dobrunick, Lyn B
Urba, Walter J
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01416831 at ClinicalTrials.govDocuments that mention this clinical trial
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma
https://doi.org/10.1136/jitc-2020-000773
NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8<sup>+</sup> T cell responses capable of curing multi-focal cancer
https://doi.org/10.1136/jitc-2019-000464
-
Funding
Funding for this research was provided by:
Center for Scientific Review (NIH R-21 CA176705-02)
Clinigen, Inc.
Prometheus
Providence Portland Medical Foundation
- License Information
